Avenues Home Care(TM) Brings Together South's Leading Independent Home Care Agencies

May 21, 2024 6:00 AM

Founders committed to professionalism, compassion, and excellenceNASHVILLE, TN / ACCESSWIRE / May 21, 2024 / A group of leading experts in home and healthcare services in the South announced today the launch of Avenues Home Care™, dedicated to providing quality, reliable, and trustworthy care to adults, seniors, and veterans in need. Avenues Home Care leverages its expertise and local community knowledge to provide home care services across...

Read more

Dr. Philip Fan J.P. (范榮彰博士) Launches Comprehensive Dental Clinic in Shenzhen

May 21, 2024 2:00 AM

The lifting of pandemic travel restrictions has driven a surge of Hong Kongers visiting mainland China for consumption, with dental services becoming a popular spending category. The dental clinic opened in Shenzhen by Dr. Philip Fan, J.P. (范榮彰博士), the former Chairman of the Board of Directors, Tung Wah Group of Hospitals and the founder of Beame (自有光), has seen tremendous popularity with Hong Kong customers, at one point serving nearly 1,000...

Read more

IRLAB Presents at ABGSC Investor Days

May 21, 2024 1:20 AM

GOTHENBURG, SWEDEN / ACCESSWIRE / May 21, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 21, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will present at ABGSC Investor Days in Stockholm on Thursday, May 23.IRLAB will be represented by Gunnar Olsson, CEO, who will give 30-minute presentation of...

Read more

Cantargia Publishes Interim Report for the First Quarter of 2024

May 21, 2024 1:20 AM

LUND, SE / ACCESSWIRE / May 21, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) today announced its interim report for the first quarter of 2024."The year has started very well for Cantargia and our clinical project, CAN10, has come into the spotlight. CAN10 has great potential for the treatment of various inflammatory diseases, and new results from our own and competitors' studies reinforce this view....

Read more

Charlie's Holdings Reports First Quarter 2024 Results

May 20, 2024 5:20 PM

Increasing Awareness and Market Share of SPREE BAR™ - with Proprietary Metatine™ Inside - Throughout 2024COSTA MESA, CA / ACCESSWIRE / May 20, 2024 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported results for the three months ended March 31, 2024, and provided an update on recent business highlights. Key Financial Highlights for Q1 2024 (compared...

Read more

Coastal Vision Medical Group Pioneers SMILE Pro With the VisuMax(R) 800

May 20, 2024 2:30 PM

First Practice West of Dallas to Offer Revolutionary Vision Correction TechnologyORANGE, CA / ACCESSWIRE / May 20, 2024 / Coastal Vision Medical Group proudly announces the successful completion of the first ZEISS SMILE procedures using the cutting-edge VisuMax® 800 laser at their Orange, CA, location (363 S Main St #325, Orange, CA 92868). This marks a significant milestone as Coastal Vision becomes the first practice west of Dallas, Texas, to...

Read more

Fast Pace Health Recognizes Mental Health Awareness Month and Expands Access to Care

May 20, 2024 1:30 PM

FRANKLIN, TN / ACCESSWIRE / May 20, 2024 / At the core of Fast Pace Health's mission lies a profound commitment to the mental well-being of the communities we serve. This dedication is particularly notable during May's Mental Health Awareness Month, a vital opportunity to raise awareness about the urgent need for compassionate and comprehensive mental health care. Fast Pace Health is increasing access to care by adding Ashley Graves,...

Read more

Emergency Care Partners Recognized as One of the Best Places to Work in Healthcare 2024

May 20, 2024 12:15 PM

CHICAGO, IL / ACCESSWIRE / May 20, 2024 / Emergency Care Partners (ECP) has been selected by Modern Healthcare as one of the 2024 Best Places to Work in Healthcare. The complete list of this year's winners, in alphabetical order, is available at ModernHealthcare.com/bestplaceslist. Modern Healthcare will publish a special supplement featuring a ranked list of all the winners along with the October 14, 2024, issue of MH magazine. "With all the...

Read more

Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 as Monotherapy or Combined with an anti-PD-L1, along with an Increase in the Dose-Escalation Target

May 20, 2024 9:15 AM

Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing targeted immunotherapeutic drugs, announced today that the safety of SON-1010 dosing has been formally reviewed in both of the current Phase 1 clinical trials and the Company is now increasing the target dose of SON-1010 during dose escalation. SON-1010 is a proprietary version of recombinant human interleukin-12 (rhIL-12),...

Read more

VivaWell and Shen.AI Announce Strategic Partnership to Transform Health Monitoring in Mexico and Argentina

May 20, 2024 9:00 AM

In a significant move to revolutionize digital health and wellness in Mexico and Argentina, Shen.AI, a leader in Face-Scanning Technology for remote vital signs monitoring, is thrilled to announce its collaboration with VivaWell, a pioneering healthtech in Latin America. This partnership is set to redefine preventive health care and wellness, making advanced health monitoring accessible to corporations and individuals across Mexico and...

Read more

Nava Health To Attend 4th Annual Benchmark Virtual Healthcare Conference

May 20, 2024 8:30 AM

COLUMBIA, MD / ACCESSWIRE / May 20, 2024 / Nava Health MD, Inc. ("Nava Health" or "Nava"), a leader in longevity, integrative and functional medicine, today announced that CEO Bernie Dancel will attend the 4th Annual Benchmark Healthcare House Call Virtual Investor Conference on Tuesday, May 21, 2024. Nava will participate in a fireside chat at 12:45pm ET and Mr. Dancel will be available for one-on-one meetings throughout the day. To register...

Read more

CNS Pharmaceuticals to Present at Alliance Global Partner's 2024 Healthcare Company Showcase

May 20, 2024 8:30 AM

Live webcast fireside chat on Tuesday, May 21st at 1:40 PM ETHOUSTON, TX / ACCESSWIRE / May 20, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals will participate in a fireside chat at the...

Read more

Hypha Labs Announces New Patent Filing

May 20, 2024 8:30 AM

New Patent Portfolio Unveiled Revolutionizing Psilocybin ProcessingLAS VEGAS, NV / ACCESSWIRE / May 20, 2024 / Hypha Labs, Inc. (OTC PINK:DIGP) Today marks a significant milestone in the realm of mycological innovation as Hypha Labs, Inc., a pioneer in functional mushroom sciences, proudly announces the initiation of a groundbreaking patent portfolio. This portfolio, spearheaded by an initial filing with the United States Patent and Trademark...

Read more

Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating Potential Cure

May 20, 2024 6:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that the strong antiviral activity of NV-387 against RSV/A2 is clearly demonstrated by lungs remaining normal and showing no infection-related damage, when treated orally with NV-387, in a lethal lung RSV infection animal model. The animals in only the NV-387 treated group survived completely, as previously reported. The...

Read more

Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate

May 20, 2024 6:00 AM

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that it received approval from the US Food and Drug Administration (FDA) for an Abbreviated New Drug Application (ANDA) for generic Methotrexate Sodium 2.5 mg tablets. Methotrexate belongs to a class of drugs known as antimetabolites and will be sold under the Elite Laboratories, Inc. label....

Read more

Spago Nanomedical Provides an Update on Tumorad-01 - Trial Proceeds as Planned

May 20, 2024 2:20 AM

LUND, SWEDEN / ACCESSWIRE / May 20, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) announced today that both of the clinical sites in the phase I/IIa study Tumorad-01 are actively recruiting patients. So far two patients have been enrolled and successfully dosed. A third patient is enrolled and awaits treatment, with a fourth patient also identified. The study continues according to plan, with focus on recruiting...

Read more

AI/ML Innovations Inc. Announces Agreement with Moonshot Inc.

May 17, 2024 5:30 PM

AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that it has entered into an independent contractor agreement (the "Agreement") with Moonshot Inc. (the "Contractor") to set out the terms and conditions of the Contactor's ongoing services to be provided to the Company (the "Services"). The Services will generally consist of the Contractor providing the services of Paul Duffy to serve as...

Read more

StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational Update

May 17, 2024 4:30 PM

TORONTO, ON / ACCESSWIRE / May 17, 2024 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for screening for multiple, key cancers from a single sample of blood - Aristotle, and an oncologist-led adjunctive treatment protocol with early data - METRICS study - showing an improvement in outcome in cancer patients, announced its first quarter...

Read more

Jaguar Health, Inc. Announces Reverse Stock Split

May 17, 2024 4:15 PM

SAN FRANCISCO, CA / ACCESSWIRE / May 17, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that the Company will effect a reverse stock split of its issued and outstanding voting common stock ("Common Stock"), at an exchange ratio of 1-for-60, on Thursday, May 23, 2024 (the "Effective Date") in order to support the Company's compliance with Nasdaq's listing standards. The Company's Common Stock will begin...

Read more

Avenir Wellness Solutions Reports Fourth Quarter 2023 Results

May 17, 2024 1:15 PM

New Initiatives Showing Encouraging ResultsSHERMAN OAKS, CA / ACCESSWIRE / May 17, 2024 / Avenir Wellness Solutions, Inc. (OTCQB:AVRW) ("Avenir" or the "Company"), a proprietary broad platform technology and wellness company, today announced results for the fourth fiscal quarter ended December 30, 2023.Key financial highlights for the fourth quarter included the following:Net revenue in the fourth quarter of 2023 increased to $1.1 million from...

Read more